论文部分内容阅读
近年来,仿制药品过境贸易引起较多的国际知识产权保护纷争。自印度在WTO下启动争端解决磋商程序后,欧盟对过境货物采取的高保护边境措施成为国际关注焦点,欧盟海关1383/2003条例引起合法性质疑。
In recent years, the cross-border trade in generic drugs has caused more disputes over the protection of international intellectual property rights. Since India initiated the dispute settlement consultation process under the WTO, the EU’s high protection of border crossings has become the focus of international attention. The EU Customs Regulation 1383/2003 has raised the question of legitimacy.